Our findings reveal that inhibitors of bromodomain proteins (specifically BRD4) promote OAd replication and increase virus-mediated cancer cell killing both in vitro and in vivo in preclinical models of PDAC by greatly increasing early viral gene expression, especially the essential E1A protein. The gene discussed is BRD4; the disease is cancer.